Neojusticin B

Neojusticin B

SCHEMBL15920775

COc1cc2c(OC)c3c(c(-c4ccc5c(c4)OCO5)c2cc1OC)COC3=O

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.72
MAPT P10636 3/20 0.72
KDM4E B2RXH2 2/20 0.72
NPSR1 Q6W5P4 2/20 0.72
LMNA P02545 2/20 0.71
HPGD P15428 2/20 0.71
MEN1 O00255 1/20 0.71
HTT P42858 1/20 0.71
KMT2A Q03164 1/20 0.71
ALOX5 P09917 5/20 0.68
TOP2A P11388 1/20 0.57
TP53 P04637 1/20 0.48
CYP3A4 P08684 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HSD17B10 Q99714 1/20 0.48
PDE1A P54750 2/20 0.47
PDE1B Q01064 2/20 0.47
PDE3B Q13370 2/20 0.47
PDE1C Q14123 2/20 0.47
PDE3A Q14432 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Neojusticin B SCHEMBL30190318 1.00 ALDH1A1 (0.72) ALDH1A1MAPTKDM4ENPSR1LMNA
Neojusticin B SCHEMBL30471811 1.00 ALDH1A1 (0.72) ALDH1A1MAPTKDM4ENPSR1LMNA
Neojusticin A SCHEMBL15624855 0.95 MAPT (0.65) ALDH1A1MAPTKDM4ENPSR1LMNA
Neojusticin A SCHEMBL30637475 0.95 MAPT (0.65) ALDH1A1MAPTKDM4ENPSR1LMNA
SCHEMBL4089401 0.92 TOP2A (0.67) ALDH1A1MAPTKDM4ENPSR1LMNA
Justicidin A SCHEMBL168356 0.91 ALDH1A1 (0.82) ALDH1A1MAPTKDM4ENPSR1LMNA
Justicidin A SCHEMBL30368670 0.91 ALDH1A1 (0.82) ALDH1A1MAPTKDM4ENPSR1LMNA
SCHEMBL17280386 0.91 ALDH1A1 (0.60) ALDH1A1MAPTKDM4ENPSR1LMNA
Justicidin A SCHEMBL29731045 0.91 ALDH1A1 (0.82) ALDH1A1MAPTKDM4ENPSR1LMNA
Taiwanin E Methyl Ether SCHEMBL30637589 0.86 MAPT (0.74) ALDH1A1MAPTKDM4ENPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240368104-A1 Novel Dialkoxynaphtho[2,3-C]Furan-1(3H)-One Derivatives and Pharmaceutical Composition For Preventing or Treating Respiratory Disease or SARS-COV-2 Infection Disease, Comprising Same DONG WHA PHARM. CO., LTD. (KR) 2024-11-07 US claimed
US-20150336938-A1 METHOD FOR PREPARATION OF JUSTICIDIN A DERIVATIVES OF ARYLNAPHTHALENE LIGNAN STRUCTURE KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2015-11-26 US claimed
WO-2014119892-A1 METHOD FOR PREPARATION OF JUSTICIDIN A DERIVATIVES OF ARYLNAPHTHALENE LIGNAN STRUCTURE KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2014-08-07 WO claimed
US-20240368104-A1 Novel Dialkoxynaphtho[2,3-C]Furan-1(3H)-One Derivatives and Pharmaceutical Composition For Preventing or Treating Respiratory Disease or SARS-COV-2 Infection Disease, Comprising Same DONG WHA PHARM. CO., LTD. (KR) 2024-11-07 US disclosed
US-9650355-B2 Method for preparation of justicidin a derivatives of arylnaphthalene lignan structure KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-05-16 US disclosed
US-9650355-B2 Method for preparation of justicidin a derivatives of arylnaphthalene lignan structure KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-05-16 US disclosed
US-20150336938-A1 METHOD FOR PREPARATION OF JUSTICIDIN A DERIVATIVES OF ARYLNAPHTHALENE LIGNAN STRUCTURE KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2015-11-26 US disclosed
US-20150336938-A1 METHOD FOR PREPARATION OF JUSTICIDIN A DERIVATIVES OF ARYLNAPHTHALENE LIGNAN STRUCTURE KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2015-11-26 US disclosed
WO-2014119892-A1 METHOD FOR PREPARATION OF JUSTICIDIN A DERIVATIVES OF ARYLNAPHTHALENE LIGNAN STRUCTURE KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2014-08-07 WO disclosed
WO-2014119892-A1 METHOD FOR PREPARATION OF JUSTICIDIN A DERIVATIVES OF ARYLNAPHTHALENE LIGNAN STRUCTURE KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2014-08-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240368104-A1 Novel Dialkoxynaphtho[2,3-C]Furan-1(3H)-One Derivatives and Pharmaceutical Composition For Preventing or Treating Respiratory Disease or SARS-COV-2 Infection Disease, Comprising Same IL5, ACE2, IL15 ALDH1A1 525/4885MAPT 3043/4885KDM4E 3050/4885
US-20150336938-A1 METHOD FOR PREPARATION OF JUSTICIDIN A DERIVATIVES OF ARYLNAPHTHALENE LIGNAN STRUCTURE UGT1A8, NOTUM, MLN ALDH1A1 241/4885MAPT 3028/4885KDM4E 3104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.